- #399 Dharmesh Shah & family ₹9,300 Cr

About Innova Life Sciences Private Limited
Data last updated:
Innova Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of M J Exports Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 December 2003 and has been in existence for over 23 years.
Its director Dharmesh Shah and family are #399 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC143625. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹44 Lakh. It is led by directors including Amol Jashvant Shah and Ishwarprasad Gilada.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 113 Jolly Maker Chambersno2 Nariman Point, Mumbai, Maharashtra, India – 400021.
Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 1 case is pending. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.65 Cr; the latest was in March 2010.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovcare.in.
Company details
Recognitions & Rankings of Innova Life Sciences
Contact details
Innova Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is innovcare.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address113 Jolly Maker Chambersno2 Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Innova Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Innova Life Sciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
Financials of Innova Life Sciences Private Limited
FY 2025 filings availableInnova Life Sciences Private Limited reported revenue of ₹900 for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 83% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹900 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innova Life Sciences Private Limited, buy the company report.
Board of directors of Innova Life Sciences Private Limited
Innova Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amol Jashvant Shah | Director | 23 Dec 2003 | 22 Years 10 Months | Current |
| Ishwarprasad Gilada | Director | 25 Aug 2004 | 22 Years 2 Months | Current |
| Dharmesh Mahendra Shah | Director | 23 Dec 2003 | 22 Years 10 Months | Current |
Auditor
Innova Life Sciences Private Limited is audited by LALITKUMARJODHRAJKOTHARI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LALITKUMARJODHRAJKOTHARI | FY 2023 | 030917 |
Shareholding
The shareholding of Innova Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innova Life Sciences Private Limited, buy the company report.
Deals & funding
Innova Life Sciences Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.65 Cr; the latest was in March 2010.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: M J Exports Private Limited , an individual Seller: 2 individuals |
| Mar 2010 | Funding round | ₹65.6 Lakh | Investors: M J Exports Private Limited , 3 individuals |
| Feb 2009 | Funding round | ₹90.5 Lakh | Investors: M J Exports Private Limited , 3 individuals |
| Apr 2008 | Funding round | ₹8.5 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Innova Life Sciences Private Limited has 6 court cases on record: 2 filed by Innova Life Sciences, 4 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Criminal complaint | Filed against the company by BDR Pharmaceuticals International Pvt. Ltd. and Anr | Disposed |
| Bombay High Court | Criminal complaint | Filed by the company against Bayer Pharmaceuticals Pvt Ltd and 2 others | Disposed |
| Bombay High Court | Court case (CHS) | Filed against the company by M/S.Bdr Lifescience Private Limited and Anr. | Pending |
| Bombay High Court | Court case (CHOL) | Filed by the company against Bayer Corporation and Anr | Disposed |
| Bombay High Court | Commercial suit | Filed against the company by Bayer Corporation and Anr | Disposed |
To see the full case history of Innova Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innova Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Innova Life Sciences Private Limited has 1 active EPFO establishment as of Apr 10, 2024.
GST
Innova Life Sciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Innova Life Sciences Private Limited, buy the company report.
Recent activity
Innova Life Sciences Private Limited has 3 board changes on record since 2003: 3 appointments. The latest: Ishwarprasad Gilada was appointed as Director on 25 Aug 2004.
Frequently asked questions
Innova Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 December 2003 (23+ years old) and is registered under CIN U24230MH2003PTC143625.
Innova Life Sciences has 3 current directors:
- Amol Jashvant Shah - Director
- Ishwarprasad Gilada - Director
- Dharmesh Mahendra Shah - Director
The latest financial statements of Innova Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Innova Life Sciences has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Innova Life Sciences is U24230MH2003PTC143625. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innova Life Sciences has 6 court cases on record: 2 filed by the company and 4 filed against it. 1 is pending.
Innova Life Sciences was incorporated on 23 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Innova Life Sciences has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.65 Cr; the latest was in March 2010.
Ishwarprasad Gilada was appointed as Director on 25 Aug 2004. Amol Jashvant Shah was appointed as Director on 23 Dec 2003. Dharmesh Mahendra Shah was appointed as Director on 23 Dec 2003.
Innova Life Sciences can be reached through the website innovcare.in. Its registered office is in Mumbai, Maharashtra, India.